Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ·Healthcare·Biotechnology
$538.81
-2.26%
Mkt Cap $12.55B
Analyst Ratings
Buy
4
Hold
2
Sell
0
Price Target (35 analysts)
$656.00
Range $542.00 – $964.00
Implied Upside
+21.7%
Consensus $656.00 vs current $538.81